“Quantitative Analysis Of CD133 & OCT 4 As Prognostic Markers In Oral Squamous Cell Carcinoma” (2023) Journal of Pharmaceutical Negative Results, pp. 2801–2811. doi:10.47750/pnr.2023.14.03.354.